UCB S.A.:企業のM&A・事業提携・投資動向

◆英語タイトル:UCB S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2134
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:206
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ベルギー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

UCB S.A. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s UCB S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by UCB S.A. since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes UCB S.A.’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by UCB S.A.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on UCB S.A.’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by UCB S.A. and its subsidiaries since 2007.
- Information about key financial and legal advisors for UCB S.A.’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about UCB S.A.’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Overview 9
Mergers and Acquisitions – Deal reports 10
CORPORATE VENTURING 20
Corporate Venturing – Overview 20
Corporate Venturing – Deal reports 21
PARTNERSHIP 40
Partnership – Overview 40
Partnership – Deal reports 41
CAPITAL RAISING 155
Capital Raising – Deal reports 155
DIVESTMENTS 157
Divestments – Overview 157
Divestments – Deal reports 158
PRIVATE EQUITY & OWNERSHIP 194
Private Equity and Ownership – Deal reports 194
APPENDIX 196
Contact Us 196
About MarketLine Financial Deals Database 196
Deal Definition and Methodology 198
About MarketLine 205

List of Tables
Table 1: UCB S.A. M&A volume and value trend (2014-YTD2018)
Table 2: UCB S.A. M&A activity by geography (2014-YTD2018)
Table 3: UCB S.A. corporate venturing volume and value trend (2014-YTD2018)
Table 4: UCB S.A. corporate venturing by geography (2014-YTD2018)
Table 5: UCB S.A. partnership volume and value trend (2014-YTD2018)
Table 6: UCB S.A. partnership trend by key deal type (2014-YTD2018)
Table 7: UCB S.A. divestments volume and value trend (2014-YTD2018)
Table 8: UCB S.A. divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: UCB S.A. M&A volume and value trend (2014-YTD2018)
Figure 2: UCB S.A. M&A activity by geography (2014-YTD2018)
Figure 3: UCB S.A. corporate venturing volume and value trend (2014-YTD2018)
Figure 4: UCB S.A. corporate venturing by geography (2014-YTD2018)
Figure 5: UCB S.A. partnership volume and value trend (2014-YTD2018)
Figure 6: UCB S.A. partnership trend by key deal type (2014-YTD2018)
Figure 7: UCB S.A. divestments volume and value trend (2014-YTD2018)
Figure 8: UCB S.A. divestments by geography (2014-YTD2018)

★海外企業調査レポート[UCB S.A.:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Great Eastern Holdings Limited (G07):企業の財務・戦略的SWOT分析
    Great Eastern Holdings Limited (G07) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • CNX Resources Corp (CNX):企業の財務・戦略的SWOT分析
    CNX Resources Corp (CNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Novartis Pharmaceuticals Corp-製薬・医療分野:企業M&A・提携分析
    Summary Novartis Pharmaceuticals Corp (Novartis), a subsidiary of Novartis AG is a developer, manufacturer and distributor of active ingredients, patent protected medicines and treatments for the healthcare industry. The company’s products include innovative prescription medicine and drugs, tablets, …
  • Wolverine World Wide Inc (WWW):企業の財務・戦略的SWOT分析
    Wolverine World Wide Inc (WWW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Rallis India Ltd (RALLIS):企業の財務・戦略的SWOT分析
    Summary Rallis India Ltd (Rallis), a subsidiary of Tata Chemicals Ltd, is an agri-solutions service provider. The company’s business portfolio includes domestic crop protection, international business, contract manufacturing, seeds, plant growth nutrients and agri services. It offers products such a …
  • Eurofins Scientific SE (ERF):製薬・医療:M&Aディール及び事業提携情報
    Summary Eurofins Scientific SE (Eurofins) is a life sciences company, which provides a range of analytical testing services to clients in various industries. The company offers food and feed testing, biopharma services, pharma discovery services, genomic pharma services, pharma early development, ph …
  • Exelon Corporation:企業のM&A・事業提携・投資動向
    Exelon Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Exelon Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Pharm-Olam International Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Pharm-Olam International Ltd (Pharm-Olam) is a contract research organization (CRO) which offers clinical research services to the pharmaceutical, biotechnology and medical device industries. The organization's service offerings include medical writing, monitoring, regulatory and ethics subm …
  • BirchBioMed Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary BirchBioMed Inc (BirchBioMed) is a biomedical company that concentrate on the development, clinical evaluation and commercialization of anti-scarring drugs, autoimmune therapeutics and novel strategies for transplantation. The company’s proprietary and patented lead drug candidate, FS2 is be …
  • Respiri Ltd (RSH):企業の財務・戦略的SWOT分析
    Respiri Ltd (RSH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • MDI Achieve Inc-医療機器分野:企業M&A・提携分析
    Summary MDI Achieve Inc (MDI), formerly MDI Technologies Inc is a technology company that designs, develops and commercializes financial and clinical management solutions. The company offers MatrixCare software solutions helps in clinical and resident management, analytics management, financial mana …
  • Zanders GmbH:企業の戦略的SWOT分析
    Zanders GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Brambles Limited (BXB):企業の財務・戦略的SWOT分析
    Brambles Limited (BXB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Perry Ellis International Inc:企業のM&A・事業提携・投資動向
    Perry Ellis International Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Perry Ellis International Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • EyeGate Pharmaceuticals Inc (EYEG)-製薬・医療分野:企業M&A・提携分析
    Summary EyeGate Pharmaceuticals Inc (EyeGate) is a clinical-stage specialty pharmaceutical company that offers eye care medicines. The company offers macular edema and non-infectious anterior uveitis. It offers technologies for most prevalent issues in ophthalmic care; the existing lack of patient a …
  • Murray & Roberts Holdings Ltd (MUR):企業の財務・戦略的SWOT分析
    Murray & Roberts Holdings Ltd (MUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Oilex Ltd (OEX):石油・ガス:M&Aディール及び事業提携情報
    Summary Oilex Ltd (Oilex) is an oil and gas company that acquires, explores and develops petroleum resources. The company’s projects in Australia include STP-EPA-0106, STP-EPA-0131, and STP-EPA-0107. Its STP-EPA-0106 project is located in onshore north-western Australia. Oilex’s Indian projects are …
  • Corcept Therapeutics Inc (CORT):企業の財務・戦略的SWOT分析
    Corcept Therapeutics Inc (CORT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Denka Co Ltd (4061):企業の財務・戦略的SWOT分析
    Denka Co Ltd (4061) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • National Company KazMunayGas:企業の戦略的SWOT分析
    National Company KazMunayGas - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆